≈$11.11B Army DEFINITIVE CONTRACT W15QKN21C0012

DoD (Army contracting): ~$11.1B for COVID-19 vaccine production — a contract with Pfizer (USAspending)

Department of the Army ・2020-12-22 〜 2023-06-30

The Department of Defense (via Army contracting) awarded a contract for COVID-19 vaccine production to Pfizer. The value is about $11.1 billion ($11,110,134,066) — a case where the DoD's procurement capacity was used for the pandemic response, showing that defense is not only about weapons.

Contract key facts

RecipientPFIZER INC
Contract value$11,110,134,066 (≈$11.11B)
BranchArmy
Awarding agencyDepartment of Defense
Awarding sub-agencyDepartment of the Army
Award typeDEFINITIVE CONTRACT
Period of performance2020-12-22 〜 2023-06-30
Contract ID (PIID)W15QKN21C0012

Contract scope (original)

COVID-19 VACCINE PRODUCTION

Key points

The DoD (via Army contracting) ordered COVID-19 vaccine production
Recipient Pfizer, ~$11.1B ($11,110,134,066), December 2020–June 2023 (multi-year cumulative)
The DoD's procurement capacity (e.g., Army Contracting Command) was used for the pandemic response
Government spending extends beyond weapons to health and public health
Alongside the oral antiviral (Paxlovid) contract, a large medical-supply procurement

This contract covers COVID-19 vaccine production, run through the Department of the Army's contracting function.

What it shows is that DoD procurement extends beyond weapons to public-health domains such as the pandemic response. During the COVID-19 outbreak, the DoD's procurement capacity — such as the Army Contracting Command — was widely used for large-scale, rapid procurement of vaccines and therapeutics. Alongside the oral antiviral (Paxlovid) contract already featured on this site, it shows that large medical-supply procurements appear within defense-spending data.

This contract illustrates how government spending extends beyond "defense = weapons" to health and public health.

Why it matters

A case where the DoD's procurement function was used for large medical-supply procurement in the pandemic response. For readers in healthcare, pharma, and public health, or following government procurement, a useful read on the breadth of "defense spending."

FAQ

What data is this?

A single Department of Defense (DoD) federal procurement contract recorded in "USAspending," the U.S. open government-spending dataset. The recipient, awarding component, value, and scope are public. This site is not an official U.S. government website.

Is the amount final?

It is a cumulative figure as of collection. Large defense contracts accumulate modifications over many years, so amounts change. The latest figure is available at the source, USAspending.

Why does the DoD procure vaccines?

During the pandemic, the DoD's procurement capacity (e.g., Army Contracting Command) was used for large-scale, rapid procurement of medical supplies. Even when the awarding party is defense, the purpose is public health.

Sources (primary)

This article is an independent organization based on the U.S. official spending data below. Verify the exact, latest details with the official source.

USAspending (award details)
Contract ID (PIID)：W15QKN21C0012

#Defense#Department of Defense#Army#COVID-19#Vaccine#Public health

← Back to the defense ranking